Rwanda’s Minister of Health, Sabin Nsanzimana, announced on Thursday that the country has successfully ended its outbreak of the deadly Marburg virus, reporting no new cases for nearly two weeks. The outbreak, which began in late September, prompted swift action, including the rollout of vaccinations in October.
Speaking at a press briefing organized by the Africa Centres for Disease Control and Prevention (Africa CDC), Nsanzimana confirmed that efforts to contain the virus have been effective. “Since then, we have been fighting this virus to make sure it’s controlled in Rwanda,” he said. “I am very happy to report here today that it has been almost two weeks without a case and a month without a death related to Marburg disease.”
He added, “Marburg virus in Rwanda is over. All patients being treated for this virus are being discharged… we are making very good progress.”
Controlled Spread and Swift Response
The Africa CDC had earlier indicated in October that the outbreak was under control, with chief Jean Kaseya describing the risk of cross-border transmission as “almost zero.” Rwanda’s health authorities implemented widespread surveillance and began vaccinating against the virus, which is transmitted to humans from fruit bats and is part of the same family as Ebola.
Lower Mortality Rate in Rwanda
While Marburg typically has a fatality rate of up to 88%, the outbreak in Rwanda saw a significantly lower mortality rate of 23%. Nsanzimana reported that out of 66 confirmed cases, 15 people died. The health minister credited the reduced mortality rate to early detection, prompt medical care, and a robust vaccination campaign.
Ongoing Vigilance
Despite declaring the outbreak over, Rwandan authorities remain cautious. Nsanzimana emphasized the importance of continued monitoring and surveillance of fruit bats, which are natural hosts of the virus. “We remain vigilant,” he said, noting that increased efforts to track the virus in wildlife will help prevent future outbreaks.
About the Marburg Virus
The Marburg virus causes a highly infectious haemorrhagic fever that can lead to severe bleeding, organ failure, and death. Symptoms often include fever, muscle pains, vomiting, and diarrhea. The disease poses a significant threat due to its high fatality rate and potential for rapid transmission.
Rwanda’s handling of the outbreak underscores the importance of coordinated health responses and early intervention in managing public health emergencies.
